Skip to main content
Top
Published in: Clinical and Molecular Allergy 1/2012

Open Access 01-12-2012 | Research

Enhanced effects of cigarette smoke extract on inflammatory cytokine expression in IL-1β-activated human mast cells were inhibited by Baicalein via regulation of the NF-κB pathway

Authors: David S Chi, Ta-Chang Lin, Kenton Hall, Tuanzhu Ha, Chuanfu Li, Zong Doa Wu, Thomas Soike, Guha Krishnaswamy

Published in: Clinical and Molecular Allergy | Issue 1/2012

Login to get access

Abstract

Background

Human mast cells are capable of a wide variety of inflammatory responses and play a vital role in the pathogenesis of inflammatory diseases such as allergy, asthma, and atherosclerosis. We have reported that cigarette smoke extract (CSE) significantly increased IL-6 and IL-8 production in IL-1β-activated human mast cell line (HMC-1). Baicalein (BAI) has anti-inflammatory properties and inhibits IL-1β- and TNF-α-induced inflammatory cytokine production from HMC-1. The goal of the present study was to examine the effect of BAI on IL-6 and IL-8 production from CSE-treated and IL-1β-activated HMC-1.

Methods

Main-stream (Ms) and Side-stream (Ss) cigarette smoke were collected onto fiber filters and extracted in RPMI-1640 medium. Two ml of HMC-1 at 1 × 106 cells/mL were cultured with CSE in the presence or absence of IL-1β (10 ng/mL) for 24 hrs. A group of HMC-1 cells stimulated with both IL-1β (10 ng/ml) and CSE was also treated with BAI. The expression of IL-6 and IL-8 was assessed by ELISA and RT-PCR. NF-κB activation was measured by electrophoretic mobility shift assay (EMSA) and IκBα degradation by Western blot.

Results

Both Ms and Ss CSE significantly increased IL-6 and IL-8 production (p < 0.001) in IL-1β-activated HMC-1. CSE increased NF-κB activation and decreased cytoplasmic IκBα proteins in IL-1β-activated HMC-1. BAI (1.8 to 30 μM) significantly inhibited production of IL-6 and IL-8 in a dose-dependent manner in IL-1β-activated HMC-1 with the optimal inhibition concentration at 30 μM, which also significantly inhibited the enhancing effect of CSE on IL-6 and IL-8 production in IL-1β-activated HMC-1. BAI inhibited NF-κB activation and increased cytoplasmic IκBα proteins in CSE-treated and IL-1β-activated HMC-1.

Conclusions

Our results showed that CSE significantly increased inflammatory cytokines IL-6 and IL-8 production in IL-1β-activated HMC-1. It may partially explain why cigarette smoke contributes to lung and cardiovascular diseases. BAI inhibited the production of inflammatory cytokines through inhibition of NF-κB activation and IκBα phosphorylation and degradation. This inhibitory effect of BAI on the expression of inflammatory cytokines induced by CSE suggests its usefulness in the development of novel anti-inflammatory therapies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Krishnaswamy G, Kelley J, Johnson D, Youngberg G, Stone W, Huang SK, Bieber J, Chi DS: The human mast cell: functions in physiology and disease. Front Biosci. 2001, 6: D1109-1127. 10.2741/krishnasCrossRef Krishnaswamy G, Kelley J, Johnson D, Youngberg G, Stone W, Huang SK, Bieber J, Chi DS: The human mast cell: functions in physiology and disease. Front Biosci. 2001, 6: D1109-1127. 10.2741/krishnasCrossRef
2.
go back to reference Krishnaswamy G, Ajitawi O, Chi DS: The human mast cell: an overview. Methods Mol Biol. 2006, 315: 13-34.PubMed Krishnaswamy G, Ajitawi O, Chi DS: The human mast cell: an overview. Methods Mol Biol. 2006, 315: 13-34.PubMed
3.
go back to reference Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ: Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev. 2007, 217: 304-328. 10.1111/j.1600-065X.2007.00520.xCrossRefPubMed Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ: Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev. 2007, 217: 304-328. 10.1111/j.1600-065X.2007.00520.xCrossRefPubMed
4.
go back to reference Igarashi Y, Goldrich MS, Kaliner MA, Irani AM, Schwartz LB, White MV: Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects. J Allergy Clin Immunol. 1995, 95: 716-725. 10.1016/S0091-6749(95)70177-XCrossRefPubMed Igarashi Y, Goldrich MS, Kaliner MA, Irani AM, Schwartz LB, White MV: Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects. J Allergy Clin Immunol. 1995, 95: 716-725. 10.1016/S0091-6749(95)70177-XCrossRefPubMed
5.
go back to reference Brightling CE, Symon FA, Birring SS, Bradding P, Wardlaw AJ, Pavord ID: Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax. 2003, 58: 528-532. 10.1136/thorax.58.6.528PubMedCentralCrossRefPubMed Brightling CE, Symon FA, Birring SS, Bradding P, Wardlaw AJ, Pavord ID: Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax. 2003, 58: 528-532. 10.1136/thorax.58.6.528PubMedCentralCrossRefPubMed
6.
go back to reference Garriga MM, Friedman MM, Metcalfe DD: A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol. 1988, 82: 425-432. 10.1016/0091-6749(88)90015-2CrossRefPubMed Garriga MM, Friedman MM, Metcalfe DD: A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol. 1988, 82: 425-432. 10.1016/0091-6749(88)90015-2CrossRefPubMed
7.
go back to reference Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB: Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science. 2002, 297: 1689-1692. 10.1126/science.1073176CrossRefPubMed Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB: Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science. 2002, 297: 1689-1692. 10.1126/science.1073176CrossRefPubMed
8.
go back to reference Castells M: Mast cell mediators in allergic inflammation and mastocytosis. Immunol Allergy Clin North Am. 2006, 26: 465-485. 10.1016/j.iac.2006.05.005CrossRefPubMed Castells M: Mast cell mediators in allergic inflammation and mastocytosis. Immunol Allergy Clin North Am. 2006, 26: 465-485. 10.1016/j.iac.2006.05.005CrossRefPubMed
9.
go back to reference Baumann H, Jahreis GP, Sauder DN, Koj A: Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse. J Biol Chem. 1984, 259: 7331-7342.PubMed Baumann H, Jahreis GP, Sauder DN, Koj A: Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse. J Biol Chem. 1984, 259: 7331-7342.PubMed
10.
go back to reference Okada M, Sakaguchi N, Yoshimura N, Hara H, Shimizu K, Yoshida N, Yoshizaki K, Kishimoto S, Yamamura Y, Kishimoto T: B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J Exp Med. 1983, 157: 583-590. 10.1084/jem.157.2.583CrossRefPubMed Okada M, Sakaguchi N, Yoshimura N, Hara H, Shimizu K, Yoshida N, Yoshizaki K, Kishimoto S, Yamamura Y, Kishimoto T: B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J Exp Med. 1983, 157: 583-590. 10.1084/jem.157.2.583CrossRefPubMed
11.
12.
go back to reference Cannon JG, Evans WJ, Hughes VA, Meredith CN, Dinarello CA: Physiological mechanisms contributing to increased interleukin-1 secretion. J Appl Physiol. 1986, 61: 1869-1874.PubMed Cannon JG, Evans WJ, Hughes VA, Meredith CN, Dinarello CA: Physiological mechanisms contributing to increased interleukin-1 secretion. J Appl Physiol. 1986, 61: 1869-1874.PubMed
13.
go back to reference Chi DS, Fitzgerald SM, Pitts S, Cantor K, King E, Lee SA, Huang SK, Krishnaswamy G: MAPK-dependent regulation of IL-1- and beta-adrenoreceptor-induced inflammatory cytokine production from mast cells: implications for the stress response. BMC Immunol. 2004, 5: 22. 10.1186/1471-2172-5-22PubMedCentralCrossRefPubMed Chi DS, Fitzgerald SM, Pitts S, Cantor K, King E, Lee SA, Huang SK, Krishnaswamy G: MAPK-dependent regulation of IL-1- and beta-adrenoreceptor-induced inflammatory cytokine production from mast cells: implications for the stress response. BMC Immunol. 2004, 5: 22. 10.1186/1471-2172-5-22PubMedCentralCrossRefPubMed
14.
go back to reference Lee SA, Fitzgerald SM, Huang SK, Li C, Chi DS, Milhorn DM, Krishnaswamy G: Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta. Am J Respir Cell Mol Biol. 2004, 31: 283-291. 10.1165/rcmb.2004-0089OCCrossRefPubMed Lee SA, Fitzgerald SM, Huang SK, Li C, Chi DS, Milhorn DM, Krishnaswamy G: Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta. Am J Respir Cell Mol Biol. 2004, 31: 283-291. 10.1165/rcmb.2004-0089OCCrossRefPubMed
16.
go back to reference Lin CC, Shieh DE: The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med. 1996, 24: 31-36. 10.1142/S0192415X96000050CrossRefPubMed Lin CC, Shieh DE: The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med. 1996, 24: 31-36. 10.1142/S0192415X96000050CrossRefPubMed
17.
go back to reference Wakabayashi I: Inhibitory effects of baicalein and wogonin on lipopolysaccharide-induced nitric oxide production in macrophages. Pharmacol Toxicol. 1999, 84: 288-291. 10.1111/j.1600-0773.1999.tb01496.xCrossRefPubMed Wakabayashi I: Inhibitory effects of baicalein and wogonin on lipopolysaccharide-induced nitric oxide production in macrophages. Pharmacol Toxicol. 1999, 84: 288-291. 10.1111/j.1600-0773.1999.tb01496.xCrossRefPubMed
18.
go back to reference Li FQ, Wang T, Pei Z, Liu B, Hong JS: Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons. J Neural Transm. 2005, 112: 331-347. 10.1007/s00702-004-0213-0CrossRefPubMed Li FQ, Wang T, Pei Z, Liu B, Hong JS: Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons. J Neural Transm. 2005, 112: 331-347. 10.1007/s00702-004-0213-0CrossRefPubMed
19.
go back to reference Woo KJ, Lim JH, Suh SI, Kwon YK, Shin SW, Kim SC, Choi YH, Park JW, Kwon TK: Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity. Immunobiology. 2006, 211: 359-368. 10.1016/j.imbio.2006.02.002CrossRefPubMed Woo KJ, Lim JH, Suh SI, Kwon YK, Shin SW, Kim SC, Choi YH, Park JW, Kwon TK: Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity. Immunobiology. 2006, 211: 359-368. 10.1016/j.imbio.2006.02.002CrossRefPubMed
20.
go back to reference Cheng PY, Lee YM, Wu YS, Chang TW, Jin JS, Yen MH: Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochem Pharmacol. 2007, 73: 793-804. 10.1016/j.bcp.2006.11.025CrossRefPubMed Cheng PY, Lee YM, Wu YS, Chang TW, Jin JS, Yen MH: Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochem Pharmacol. 2007, 73: 793-804. 10.1016/j.bcp.2006.11.025CrossRefPubMed
21.
go back to reference Hsieh CJ, Hall K, Ha T, Li C, Krishnaswamy G, Chi DS: Baicalein inhibits IL-1β- and TNF-α-induced inflammatory cytokine production from human mast cells via regulation of the NF-κB pathway. Clinical Molecular Allergy. 2007, 5: 5-10.1186/1476-7961-5-5.PubMedCentralCrossRefPubMed Hsieh CJ, Hall K, Ha T, Li C, Krishnaswamy G, Chi DS: Baicalein inhibits IL-1β- and TNF-α-induced inflammatory cytokine production from human mast cells via regulation of the NF-κB pathway. Clinical Molecular Allergy. 2007, 5: 5-10.1186/1476-7961-5-5.PubMedCentralCrossRefPubMed
22.
go back to reference Fitzgerald SM, Lee SA, Hall HK, Chi DS, Krishnaswamy G: Human lung fibroblasts express interleukin-6 in response to signaling after mast cell contact. Am J Respir Cell Mol Biol. 2004, 30: 585-593.CrossRefPubMed Fitzgerald SM, Lee SA, Hall HK, Chi DS, Krishnaswamy G: Human lung fibroblasts express interleukin-6 in response to signaling after mast cell contact. Am J Respir Cell Mol Biol. 2004, 30: 585-593.CrossRefPubMed
23.
go back to reference Fitzgerald SM, Chi DS, Hall HK, Reynolds SA, Aramide O, Lee SA, Krishnaswamy G: GM-CSF induction in human lung fibroblasts by IL-1beta, TNF-alpha, and macrophage contact. J Interferon Cytokine Res. 2003, 23: 57-65. 10.1089/107999003321455453CrossRefPubMed Fitzgerald SM, Chi DS, Hall HK, Reynolds SA, Aramide O, Lee SA, Krishnaswamy G: GM-CSF induction in human lung fibroblasts by IL-1beta, TNF-alpha, and macrophage contact. J Interferon Cytokine Res. 2003, 23: 57-65. 10.1089/107999003321455453CrossRefPubMed
24.
go back to reference Li C, Browder W, Kao RL: Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart. Am J Physiol. 1999, 276: H543-552. Li C, Browder W, Kao RL: Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart. Am J Physiol. 1999, 276: H543-552.
25.
go back to reference Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL, Browder W, Williams DL: Modulating Toll-like receptor mediated signaling by (1-- > 3)-beta-D-glucan rapidly induces cardioprotection. Cardiovasc Res. 2004, 61: 538-547. 10.1016/j.cardiores.2003.09.007CrossRefPubMed Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL, Browder W, Williams DL: Modulating Toll-like receptor mediated signaling by (1-- > 3)-beta-D-glucan rapidly induces cardioprotection. Cardiovasc Res. 2004, 61: 538-547. 10.1016/j.cardiores.2003.09.007CrossRefPubMed
26.
go back to reference Li C, Kao RL, Ha T, Kelley J, Browder IW, Williams DL: Early activation of IKKbeta during in vivo myocardial ischemia. Am J Physiol Heart Circ Physiol. 2001, 280: H1264-1271. Li C, Kao RL, Ha T, Kelley J, Browder IW, Williams DL: Early activation of IKKbeta during in vivo myocardial ischemia. Am J Physiol Heart Circ Physiol. 2001, 280: H1264-1271.
27.
go back to reference Li C, Ha T, Liu L, Browder W, Kao RL: Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart. Surgery. 2000, 127: 161-169. 10.1067/msy.2000.101582CrossRefPubMed Li C, Ha T, Liu L, Browder W, Kao RL: Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart. Surgery. 2000, 127: 161-169. 10.1067/msy.2000.101582CrossRefPubMed
28.
go back to reference Hsieh CJ, Hall K, Krishnaswamy G, Chi DS: Differential effects of berberine, baicalein, and triptolide on cytokine production from IL-1 -activated mast cells [abstract]. J Immunol. 2007, 178: 95.28. Hsieh CJ, Hall K, Krishnaswamy G, Chi DS: Differential effects of berberine, baicalein, and triptolide on cytokine production from IL-1 -activated mast cells [abstract]. J Immunol. 2007, 178: 95.28.
29.
go back to reference Baeuerle PA, Baltimore D: NF-kappa B: ten years after. Cell. 1996, 87: 13-20. 10.1016/S0092-8674(00)81318-5CrossRefPubMed Baeuerle PA, Baltimore D: NF-kappa B: ten years after. Cell. 1996, 87: 13-20. 10.1016/S0092-8674(00)81318-5CrossRefPubMed
30.
go back to reference Baldwin AS Jr: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996, 14: 649-683. 10.1146/annurev.immunol.14.1.649CrossRefPubMed Baldwin AS Jr: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996, 14: 649-683. 10.1146/annurev.immunol.14.1.649CrossRefPubMed
31.
go back to reference Baeuerle PA, Baichwal VR: NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol. 1997, 65: 111-137.CrossRefPubMed Baeuerle PA, Baichwal VR: NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol. 1997, 65: 111-137.CrossRefPubMed
32.
go back to reference Henz BM, Maurer M, Lippert U, Worm M, Babina M: Mast cells as initiators of immunity and host defense. Exp Dermatol. 2001, 10: 1-10. 10.1034/j.1600-0625.2001.100101.xCrossRefPubMed Henz BM, Maurer M, Lippert U, Worm M, Babina M: Mast cells as initiators of immunity and host defense. Exp Dermatol. 2001, 10: 1-10. 10.1034/j.1600-0625.2001.100101.xCrossRefPubMed
33.
go back to reference Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB: Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999, 163: 3474-3483.PubMed Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB: Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999, 163: 3474-3483.PubMed
34.
go back to reference Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr: Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995, 270: 283-286. 10.1126/science.270.5234.283CrossRefPubMed Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr: Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995, 270: 283-286. 10.1126/science.270.5234.283CrossRefPubMed
35.
go back to reference Kuhn H, O'Donnell VB: Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res. 2006, 45: 334-356. 10.1016/j.plipres.2006.02.003CrossRefPubMed Kuhn H, O'Donnell VB: Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res. 2006, 45: 334-356. 10.1016/j.plipres.2006.02.003CrossRefPubMed
36.
go back to reference George J, Afek A, Shaish A, Levkovitz H, Bloom N, Cyrus T, Zhao L, Funk CD, Sigal E, Harats D: 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation. 2001, 104: 1646-1650. 10.1161/hc3901.095772CrossRefPubMed George J, Afek A, Shaish A, Levkovitz H, Bloom N, Cyrus T, Zhao L, Funk CD, Sigal E, Harats D: 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation. 2001, 104: 1646-1650. 10.1161/hc3901.095772CrossRefPubMed
37.
go back to reference Matsuyama M, Yoshimura R, Mitsuhashi M, Hase T, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T: Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Int J Oncol. 2004, 24: 821-827.PubMed Matsuyama M, Yoshimura R, Mitsuhashi M, Hase T, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T: Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Int J Oncol. 2004, 24: 821-827.PubMed
38.
go back to reference Yuan Z, Liu Y, Liu Y, Zhang J, Kishimoto C, Wang Y, Ma A, Liu Z: Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade. Heart. 2005, 91: 1203-1208. 10.1136/hrt.2004.046292PubMedCentralCrossRefPubMed Yuan Z, Liu Y, Liu Y, Zhang J, Kishimoto C, Wang Y, Ma A, Liu Z: Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade. Heart. 2005, 91: 1203-1208. 10.1136/hrt.2004.046292PubMedCentralCrossRefPubMed
39.
go back to reference Nakajima A, Wada K, Miki H, Kubota N, Nakajima N, Terauchi Y, Ohnishi S, Saubermann LJ, Kadowaki T, Blumberg RS, Nagai R, Matsuhashi N: Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology. 2001, 120: 460-469. 10.1053/gast.2001.21191CrossRefPubMed Nakajima A, Wada K, Miki H, Kubota N, Nakajima N, Terauchi Y, Ohnishi S, Saubermann LJ, Kadowaki T, Blumberg RS, Nagai R, Matsuhashi N: Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology. 2001, 120: 460-469. 10.1053/gast.2001.21191CrossRefPubMed
40.
go back to reference Appel S, Mirakaj V, Bringmann A, Weck MM, Grunebach F, Brossart P: PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood. 2005, 106: 3888-3894. 10.1182/blood-2004-12-4709CrossRefPubMed Appel S, Mirakaj V, Bringmann A, Weck MM, Grunebach F, Brossart P: PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood. 2005, 106: 3888-3894. 10.1182/blood-2004-12-4709CrossRefPubMed
41.
go back to reference Kempuraj D, Castellani ML, Petrarca C, Frydas S, Conti P, Theoharides TC, Vecchiet J: Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Clin Exp Med. 2006, 6: 150-156. 10.1007/s10238-006-0114-7CrossRefPubMed Kempuraj D, Castellani ML, Petrarca C, Frydas S, Conti P, Theoharides TC, Vecchiet J: Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Clin Exp Med. 2006, 6: 150-156. 10.1007/s10238-006-0114-7CrossRefPubMed
42.
go back to reference Castellani ML, Kempuraj D, Frydas S, Theoharides TC, Simeonidou I, Conti P, Vecchiet J: Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Neuroimmunomodulation. 2006, 13: 179-186. 10.1159/000098131CrossRefPubMed Castellani ML, Kempuraj D, Frydas S, Theoharides TC, Simeonidou I, Conti P, Vecchiet J: Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Neuroimmunomodulation. 2006, 13: 179-186. 10.1159/000098131CrossRefPubMed
43.
go back to reference Kandere-Grzybowska K, Kempuraj D, Cao J, Cetrulo CL, Theoharides TC: Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br J Pharmacol. 2006, 148: 208-215. 10.1038/sj.bjp.0706695PubMedCentralCrossRefPubMed Kandere-Grzybowska K, Kempuraj D, Cao J, Cetrulo CL, Theoharides TC: Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br J Pharmacol. 2006, 148: 208-215. 10.1038/sj.bjp.0706695PubMedCentralCrossRefPubMed
Metadata
Title
Enhanced effects of cigarette smoke extract on inflammatory cytokine expression in IL-1β-activated human mast cells were inhibited by Baicalein via regulation of the NF-κB pathway
Authors
David S Chi
Ta-Chang Lin
Kenton Hall
Tuanzhu Ha
Chuanfu Li
Zong Doa Wu
Thomas Soike
Guha Krishnaswamy
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Clinical and Molecular Allergy / Issue 1/2012
Electronic ISSN: 1476-7961
DOI
https://doi.org/10.1186/1476-7961-10-3

Other articles of this Issue 1/2012

Clinical and Molecular Allergy 1/2012 Go to the issue